Leick, Katie M.
Tomanek-Chalkley, Ann
Coleman, Kristen L.
Chan, Carlos H. F.
Funding for this research was provided by:
National Cancer Institute (P30CA086862)
Article History
Received: 6 December 2022
Accepted: 10 April 2023
First Online: 11 June 2023
Disclosure
: C.H.F.C. received research support from Checkmate Pharmaceuticals, Angiodynamics, and Optimum Therapeutics for clinical trials and research projects unrelated to this study. The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.